Introduction
============

Perianeurysmal edema is rare, but one of the serious complications following endovascular coil embolization for the intracranial aneurysm.^[@B1]--[@B11]^ Proposed mechanism for the perianeurysmal edema are acute thrombosis formation, chemical inflammation, and pulsatile blood flow transmitted to the brain parenchyma due to aneurysm recanalization.^[@B1]--[@B4]^ Recently, some reports have implicated that second generation aneurysm coils including Matrix^®^ (Stryker, Kalamazoo, Michigan, USA), Micrus Coil^®^ (Micrus Endovascular, San Jose, California, USA), and HydroCoil^®^ (MicroVention, Inc., Tustin, California, USA) are easy to induce perianeurysmal edema compared with bare platinum coils, because of an inflammatory response from the implanted materials on the coils.^[@B2],[@B4],[@B10],[@B11]^ We herein present an extremely rare case showing repeated perianeurysmal edema after endovascular coil embolization for a ruptured aneurysm with different etiologies over time, and discuss its clinical implications with a review of the literature.

Case Report
===========

A 48-year-old woman was referred to our neurosurgery department for a severe headache. Her neurological grade was Hunt & Kosnik grade 2 and World Federation of Neurological Surgeons (WFNS) grade 2. She had no history of high blood pressure or smoking. After admission, neck stiffness was evident without any neurological deficit on physical examination. Computed tomography studies of the brain confirmed subarachnoid hemorrhage (Fisher grade 3) with hydrocephalus, and digital subtraction angiography demonstrated an aneurysm at the basilar bifurcation, which extended superiorly to the midbrain ([Fig. 1A, B](#F1){ref-type="fig"}).

I.. Initial treatment and 1st perianeurysmal edema
--------------------------------------------------

Endovascular coil embolization for the aneurysm was performed under general anesthesia on the day of admission. Bare platinum coils (GDC^®^, Boston Scientific, Natick, Massachusetts, USA) were used for embolization with balloon neck remodeling technique, which resulted in a occlusion with a slightly neck remnant ([Fig. 1C](#F1){ref-type="fig"}). The postoperative course was uneventful, and the patient was discharged with no neurologic deficit. Interestingly, asymptomatic perianeurysmal edema was detected in the midbrain on fluid attenuated inversion recovery sequence with magnetic resonance imaging (FLAIR-MRI) 2 weeks after the initial treatment ([Fig. 1](#F1){ref-type="fig"}). The edema was spontaneously improved in the follow-up examination.

II.. Recanalization, re-embolization, and 2nd perianeurysmal edema
------------------------------------------------------------------

Follow-up angiogram demonstrated aneurysm recanalization and regrowth, with a perianeurysmal edema again on FLAIR-MRI 8 weeks after the initial treatment ([Fig. 2A, B](#F2){ref-type="fig"}), but she presented no obvious neurological symptoms. She underwent re-embolization with bioactive coils and bare platinum coils (Matrix^®^, Micrus Coil^®^, and GDC^®^) 9 weeks after the initial treatment, and complete occlusion was achieved ([Fig. 2C](#F2){ref-type="fig"}). However, perianeurysmal edema massively deteriorated on postoperative FLAIR-MRI at 2 days after the procedure ([Fig. 2D](#F2){ref-type="fig"}), which was spontaneously improved 4 weeks later ([Fig. 2E](#F2){ref-type="fig"}).

III.. Recanalization and 3rd perianeurysmal edema
-------------------------------------------------

Follow-up angiogram demonstrated aneurysm recanalization and regrowth again in parallel with asymptomatic perianeurysmal edema on FLAIR-MRI 16 weeks after the initial treatment ([Fig. 3A, B](#F3){ref-type="fig"}). She underwent the 3rd embolization with GDC^®^ 31 weeks after the initial treatment, and complete occlusion was achieved ([Fig. 3C](#F3){ref-type="fig"}). FLAIR-MRI 2 days after the third treatment revealed a slight improvement of the edema ([Fig. 3C](#F3){ref-type="fig"}).

Discussion
==========

Endovascular embolization of the cerebral aneurysms has become an accepted therapy for prevention or treatment of aneurysm rupture.^[@B12]--[@B14]^ A prospective, randomized, controlled trial, the international subarachnoid aneurysm trial, found that patients who underwent endovascular coiling of ruptured intracranial aneurysm had a 6.9% absolute risk reduction in dependency or death at 1 year, compared with those who underwent surgical clipping.^[@B15]^ However, the long-term efficacy and durability of endovascular coiling remains in controversial. Edema formation in the perianeurysmal region has been reported to be one of the serious complications after the endovascular treatment.

Reported cases showing perianeurysmal edema after endovascular treatment are summarized in [Table 1](#T1){ref-type="table"}.^[@B1]--[@B12]^ There were 19 patients with a mean age of 58 years. Among them, only 3 patients had ruptured aneurysm suggesting subarachnoid hemorrhage itself did not affect perianeurysmal edema formation. It is noteworthy that most cases had large aneurysm which buried in the brain parenchyma, and our case also had an enlarged aneurysm which buried in the midbrain. In terms of the coil materials, even bare platinum coils can induce perianeurysmal edema and several kinds of coils were used all together in most cases. Treatment options for perianeurysmal edema were corticosteroids and re-embolization. Medical therapy with corticosteroids was considered if the symptoms were progressive in parallel with imaging findings.^[@B4]^ The edema finally improved spontaneously or with treatment in 10 patients (52.6%).

In order to evaluate the etiology of de novo perianeurysmal edema, we divided the presumed causes of the edema into three types: acute thrombosis, chemical inflammatory reactions by the coils, recanalization of the aneurysm with mass effect.^[@B1]--[@B11]^ In most cases, chemical inflammatory reaction was considered as a main cause of the edema formation regardless of the coil types.^[@B1],[@B2],[@B4]--[@B11]^ Interestingly, perianeurysmal edema possibly due to chemical inflammation has a wide distribution of the edema onset (day 4 to day 249, median: day 21 after the initial treatment) indicating that most of the edema are asymptomatic and incidentally detected with postoperative imaging in most cases.

In the present case, repeated perianeurysmal edema following coil embolization could be classified into all the three types. In the 1st perianeurysmal edema, acute thrombosis formation in the aneurysm or chemical inflammation due to bare platinum coils could contribute to the edema since this is spontaneously resolved. Thrombus formation within the aneurysm is reported to induce cytokine release from activated platelets.^[@B16]^ On the other hand, aneurysm recanalization and regrowth could contribute to the 2nd and 3rd edema formation since the edema size was parallel with the degree of recanalization and regrowth. The pulsatile blood flow when striking the coils may result in a regrowth of the aneurysm and may also be transmitted to the aneurysm wall via the coils, thus leading to the perianeurysmal edema.^[@B3]^ In this situation, the edema improved after re-embolization of the aneurysm. Finally, chemical inflammatory reactions from second generation coils and bare platinum coils could contribute to the massive edema after 2nd re-embolization, which resolved spontaneously. The second generation coils are developed to promote healing across the aneurysm neck by inciting an intense fibrocellular response.^[@B4]^ In an experimental aneurysm model, bioabsorbable polymeric material (BPM) treated aneurysms demonstrated persistent macrophage enrichment compared to GDC,^[@B17]^ and therefore second generation coils could enhance inflammatory reactions after the embolization.

We describe an extremely rare case of a ruptured aneurysm showing repeated perianeurysmal edema after endovascular coil embolization with different etiologies over time. We have to be aware of this potential complication in the long term after endovascular coil embolization for the intracranial aneurysm, especially with large size or buried into the brain parenchyma.

![Preoperative digital subtraction angiography (DSA) showing a ruptured aneurysm at the basilar bifurcation, which extended superiorly to the midbrain (A). Computed tomography showing diffuse subarachnoid hemorrhage in the basal cistern (B). Note that no perianeurysmal edema was detected preoperatively. The aneurysm was obliterated with GDCs^®^, with a slight neck remnant (C). Postoperative fluid attenuated inversion recovery sequence with magnetic resonance imaging detected perianeurysmal edema, which resolved spontaneously (*arrow* in D).](nmc-55-519-g1){#F1}

![Follow-up DSA showing aneurysm recanalization and regrowth (A) with a perianeurysmal edema on FLAIR-MRI 8 weeks after the initial treatment (B). Second embolization with Matrix^®^, Micrus Coil^®^, and GDC^®^ enabled complete obliteration of the aneurysm (C), but induced massive perianeurysmal edema in the midbrain (*arrow* in D). The edema was asymptomatic and spontaneously resolved a week after the 2nd embolization (*double arrow* in E). DSA: digital subtraction angiography, FLAIR-MRI: fluid attenuated inversion recovery-magnetic resonance imaging.](nmc-55-519-g2){#F2}

![Follow-up DSA showing aneurysm recanalization and regrowth again (A) with a perianeurysmal edema on FLAIR-MRI 16 weeks after the initial treatment (*arrow* in B). Third embolization with GDC^®^ enabled complete obliteration of the aneurysm (C), which achieved with a slight improvement of the edema (D). DSA: digital subtraction angiography, FLAIR-MRI: fluid attenuated inversion recovery-magnetic resonance imaging.](nmc-55-519-g3){#F3}

###### 

Reported cases showing perianeurysmal edema after endovascular coil embolization

  Author, year                     Age, sex          Location          Aneurysm size (mm)   Coil type in the initial Tx   Onset (day)   Presumed cause                    Treatment         Outcome
  -------------------------------- ----------------- ----------------- -------------------- ----------------------------- ------------- --------------------------------- ----------------- --------------
  Meyers et al., 2004^[@B5]^       46, F             PCA               20                   GDC, Matrix, HC               21            C                                 Corticosteroid    Improved
  Horie et al., 2007^[@B3]^        72, M             ICA paraclinoid   15                   GDC,                          180           R                                 Re-embolization   Improved
  72, F                            BA-SCA            15                GDC                  90                            R             Corticosteroid, Re-embolization   Improved          
  73, F                            ICA terminalis    16                GDC                  90                            R             Re-embolization                   Improved          
  Pickett et al., 2007^[@B7]^      55, F             ICA paraclinoid   20                   HC, BPC                       21            C                                 Corticosteroid    No change
  56, M                            ICA paraclinoid   25                HC, BPC              30                            C             Corticosteroid                    Deteriorated      
  Turner et al., 2008^[@B8]^       69, F             ICA paraclinoid   22                   HC, BPC                       14            C                                 Corticosteroid    NA
  Marden and Putman, 2008^[@B4]^   27, F             ICA terminalis    8                    GDC, Matrix                   7             C                                 None              Improved
  Fanning et al., 2008^[@B2]^      47, F             ICA paraclinoid   14                   BPC, HC                       129           R, T                              None              No change
  51, F                            ICA paraclinoid   7.3               BPC, HC              4                             C             None                              Improved          
  72, F                            ICA terminalis    10.5              BPC, HC              249                           C             NA                                NA                
  59, M                            ICA terminalis    10.2              BPC, HC              36                            C             None                              NA                
  59, M                            ICA terminalis    12.9              BPC, HC              39                            C             NA                                NA                
  White, 2008^[@B11]^              73, M             VA                17                   Orbit, Micrus, MicroPlex      7             C                                 Corticosteroid    Deteriorated
  55, M                            BA                13                MicroPlex            6                             C             NA                                NA                
  Craven et al., 2009^[@B1]^       51, F             MCA               7                    BPC                           90            C                                 None              Improved
  Vu Dang et al., 2009^[@B9]^      46, F             ICA Pcom          12                   Axium, GDC, MicroPlex         30            C                                 Corticosteroid    Improved
  Misaki et al., 2010^[@B6]^       69, F             ICA               19                   GDC, Orbit                    6             C                                 None              Improved
  Present case                     48, F             BA                6                    GDC, Matrix, Micrus           14, 63, 112   T, C, R                           Re-embolization   Improved

BA-SCA: basal artery-superior cerebellar artery, BPC: bare platinum coil, C: chemical inflammatory reactions by the coils, HC: hydro coil, ICA: internal carotid artery, MCA: middle cerebral artery, NA: not available, PCA: posteriro cerebral artery, Pcom: posterior communicating artery, R: recanalization, T: thrombosis, Tx: treatment, VA: vertebral artery.
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